05/28/2021 Dr. Guibin Qiao of the pulmonary disease department, Guangdong Provincial People’s Hospital, remarked by citing a 2020 published study by French scientists that the combined use of hydroxychloroquine and azithromycin enhances the therapeutic effect against COVID-19. He also believed that this therapeutic plan is inexpensive but safe, which is worthy of being promoted.
Note: The literature cited in the video is Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949.
By： 【秘密翻译组-精翻组 G-Translators/Elite Team】